Alzheimer's patients' cognition improves with Sargramostim (GM-CSF), new study shows

(University of Colorado Anschutz Medical Campus) A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer's disease. The University of Colorado Anschutz Medical Campus presents evidence that Sargramostim has both disease-modifying and cognition-enhancing activities in Alzheimer's disease patients.